Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CERAMEDIX HOLDING, LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-09-28 to 2024-09-27
Current total value of award: $4496897.16
Description: JW190496 FY19 NEW START RESEARCH AND DEVELOPMENT CONTRACT PROJECT TITLE: ANTICERAMIDE SCFV AS PROPHYLAXIS OF THE RADIATION GI SYNDROME